PPARG and colorectal carcinoma: Reduced survival of patients with poor CRC is associated with down-regulated PPAR-γ expression,42 and functional loss-of-function mutations in PPAR-γ are associated with human CRC.43 Therefore, clinical studies also show that PPAR-γ is an important target for preventing CRC.